Trial Profile
Phase 2 trial of MOR208 in combination with lenalidomide in patients with Diffuse-large-B-cell lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Tafasitamab (Primary) ; Lenalidomide
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Sponsors MorphoSys
- 01 Aug 2016 Status changed from planning to recruiting, as reported in a MorphoSys media release.
- 28 Mar 2016 New trial record